Dynamic Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-900
Closed -$318K 37
2018
Q3
$318K Buy
+900
New +$310K 0.43% 62
2017
Q4
Sell
-5,218
Closed -$1.63M 239
2017
Q3
$1.63M Buy
5,218
+3,819
+273% +$1.13M 0.47% 53
2017
Q2
$380K Buy
+1,399
New +$370K 0.09% 192
2017
Q1
Sell
-7,699
Closed -$2.18M 282
2016
Q4
$2.18M Sell
7,699
-1,473
-16% -$437K 0.23% 138
2016
Q3
$2.87M Buy
+9,172
New +$2.72M 0.37% 80
2015
Q2
Sell
-23,200
Closed -$9.8M 266
2015
Q1
$9.8M Buy
+23,200
New +$9.14M 3.52% 3
2014
Q3
Sell
-1,700
Closed -$536K 331
2014
Q2
$536K Sell
1,700
-1,680
-50% -$506K 0.15% 238
2014
Q1
$1.03M Buy
3,380
+1,680
+99% +$533K 0.34% 85
2013
Q4
$475K Buy
+1,700
New +$440K 0.09% 321

Other funds holding BIIB

Dynamic Capital Management's BIIB Position: Q4 2018 in Review

Dynamic Capital Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 900 shares — an estimated $318K sold.

Dynamic Capital Management first reported a position in BIIB in Q4 2013 and held it in 9 quarters. The position peaked at $9.8M in Q1 2015. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Dynamic Capital Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Dynamic Capital Management sold 900 Biogen shares in Q4 2018, an estimated $318K.
  • Dynamic Capital Management first reported a position in Biogen in Q4 2013 and held it in 9 quarters.
  • Dynamic Capital Management's Biogen position peaked at $9.8M in Q1 2015.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Dynamic Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.